How Cancer Treatment Causes Eyebrow and Eyelash Loss — and What You Can Do About It

Hair loss is one of the most visible and emotionally difficult side effects of cancer treatment. While most people associate chemotherapy with losing the hair on their head, many don’t realize until it happens that eyebrows and eyelashes are often affected too — and for many patients, losing their brows hits harder than they expected.

Understanding why cancer treatments cause hair loss, which treatments are most likely to affect your eyebrows and lashes, and what options exist for managing it can help you feel more prepared and more in control during an already challenging time.

Why Does Cancer Treatment Cause Hair Loss?

To understand why cancer treatment leads to hair loss, it helps to understand how these treatments work at the cellular level.

Chemotherapy and Hair Follicles

Chemotherapy drugs are designed to target rapidly dividing cells — which is how they attack cancer. The problem is that hair follicle cells are among the fastest-dividing cells in the human body. Hair matrix cells in the follicle divide approximately every 23 to 72 hours, making them highly susceptible to the same mechanisms that chemotherapy uses to destroy cancer cells.

When chemotherapy drugs circulate through the bloodstream, they don’t distinguish between rapidly dividing cancer cells and rapidly dividing hair cells. The drugs disrupt the mitotic process — the cell division cycle — in the hair follicle, causing the hair shaft to weaken, break, or detach entirely. This type of hair loss is called anagen effluvium, because it interrupts the anagen (active growth) phase of the hair cycle.

The degree of hair loss depends on several factors: the specific chemotherapy drugs used, the dosage, the treatment schedule, and individual variation. Some drugs are more strongly associated with hair loss than others.

Which Chemotherapy Drugs Cause Eyebrow Loss?

Not all chemotherapy regimens affect the eyebrows equally. The drugs most commonly associated with significant eyebrow and eyelash loss include taxanes (docetaxel, paclitaxel), which are widely used in breast, ovarian, and lung cancers; anthracyclines (doxorubicin, epirubicin), commonly used in breast cancer and lymphomas; alkylating agents (cyclophosphamide), used across many cancer types; and topoisomerase inhibitors (etoposide, irinotecan).

Combination regimens — such as AC-T (doxorubicin, cyclophosphamide, followed by a taxane) commonly used in breast cancer — are particularly likely to cause complete hair loss including eyebrows and eyelashes.

Some chemotherapy drugs are less likely to cause significant eyebrow loss. These include certain antimetabolites like capecitabine (Xeloda) and some targeted therapies, though individual responses vary widely.

Radiation Therapy

Radiation therapy causes hair loss only in the area being treated. If radiation is directed at the head or face — as in the treatment of brain tumors, head and neck cancers, or orbital lymphomas — eyebrow loss can occur in the radiation field. Unlike chemotherapy-induced hair loss, radiation-related hair loss can sometimes be permanent if the radiation dose is high enough to damage the hair follicle stem cells.

Targeted Therapies and Immunotherapy

Newer cancer treatments like targeted therapies and immunotherapy affect hair differently than traditional chemotherapy. EGFR inhibitors (such as erlotinib and cetuximab) can actually cause changes in hair texture and growth patterns — sometimes leading to thinning of eyebrows rather than complete loss. Some patients experience a paradoxical increase in eyelash growth (trichomegaly) while losing scalp hair.

Immunotherapy drugs (checkpoint inhibitors like pembrolizumab and nivolumab) are less commonly associated with significant hair loss, but they can cause alopecia areata — an autoimmune form of hair loss — in some patients.

Hormonal Therapies

Hormonal treatments used in breast and prostate cancer — such as tamoxifen, aromatase inhibitors (letrozole, anastrozole), and anti-androgens — can cause gradual hair thinning over time, including thinning of the eyebrows. This is typically less dramatic than chemotherapy-induced loss but can be persistent since these treatments are often taken for years.

The Timeline of Eyebrow Loss During Treatment

Understanding when to expect eyebrow loss can help with planning and preparation.

Weeks 1-2 after starting chemotherapy: Hair follicles begin to be affected, but visible changes are usually not yet apparent. Some patients report tingling or tenderness in the scalp and brow area.

Weeks 2-4: Scalp hair loss typically begins first. Eyebrow thinning may start to become noticeable, often beginning at the outer edges of the brows (the “tail” of the brow).

Weeks 4-8: For regimens that cause significant hair loss, eyebrows may become substantially thinner or fall out entirely. Eyelash loss often follows a similar timeline or may lag slightly behind.

During ongoing treatment: Hair loss typically continues or remains stable throughout the treatment course. Some patients experience cycles of partial regrowth between treatment cycles, particularly with cycled regimens.

After treatment ends: Eyebrow regrowth typically begins 3 to 6 months after the completion of chemotherapy. Initial regrowth may be fine, sparse, or different in color or texture from the original hair. Full eyebrow regrowth — matching pre-treatment density and appearance — can take 6 to 12 months or longer.

The Emotional Impact of Losing Your Eyebrows

Research consistently shows that eyebrow and eyelash loss causes disproportionate emotional distress relative to scalp hair loss. A 2018 study published in Supportive Care in Cancer found that patients ranked eyebrow and eyelash loss as one of the most distressing appearance changes during chemotherapy — in some cases more distressing than scalp hair loss.

There are several reasons for this. Eyebrows play a critical role in facial expression and nonverbal communication. They convey emotion — surprise, concern, skepticism, warmth — in ways that are deeply embedded in human social interaction. When eyebrows are absent, the face can appear expressionless or unfamiliar, even to the person looking in the mirror.

Eyebrows also serve as a strong marker of identity. Many people develop a close relationship with their brow shape over years of grooming and care. Losing that feature can feel like losing a piece of yourself — compounding the identity disruption that cancer diagnosis and treatment already creates.

Additionally, while wigs provide a well-known solution for scalp hair loss, eyebrow solutions are less widely discussed. Many patients don’t learn about their options until after the loss has already occurred, adding an element of surprise and helplessness to the experience.

Solutions for Eyebrow Loss During Cancer Treatment

Several options exist for managing eyebrow loss during and after cancer treatment, each with different advantages depending on your situation, skin sensitivity, and preferences.

Temporary Eyebrow Tattoos

Temporary eyebrow tattoos have become one of the most practical and popular solutions for cancer patients experiencing brow loss. They offer several specific advantages for people in treatment.

They’re non-invasive — nothing penetrates the skin, which is important for patients who may be immunocompromised during chemotherapy. They require no healing time and carry no infection risk. They’re easy to apply and remove, which matters when energy levels are limited. They can be adjusted as brow loss progresses — you can switch from a design that fills in thinning brows to one that provides complete brow coverage as needed. And they provide immediate, natural-looking results without requiring the skill or steady hand that brow pencils and powders demand.

At Brow Again, we designed our temporary eyebrow tattoos with cancer patients specifically in mind. Our products use skin-safe, hypoallergenic adhesives that are gentle on sensitized skin — because we know that chemotherapy can make skin more reactive and fragile. Each pair features realistic hair-stroke designs that look natural, not drawn on, and they’re available in multiple shapes and colors to match your natural brow.

Brow Pencils and Powders

Cosmetic products like brow pencils, powders, and pomades can be effective for filling in thinning brows. They require some practice and a steady hand, and they need to be reapplied daily. For patients with complete brow loss, pencils and powders can be more challenging to use because there’s no existing hair to build on — and the results may look less natural without a template to follow.

Microblading and Permanent Makeup

Microblading and cosmetic tattooing create semi-permanent or permanent eyebrow designs by depositing pigment into the skin. While these can produce excellent results, they’re generally not recommended during active cancer treatment. The procedure involves breaking the skin, which poses infection risk for immunocompromised patients. Most dermatologists and oncologists recommend waiting until at least 6 to 12 months after treatment completion, and until blood counts have fully normalized, before considering microblading.

Eyebrow Wigs and Prosthetics

Adhesive eyebrow wigs made from human or synthetic hair are available and can provide a natural appearance. They tend to be more expensive than temporary tattoos and can be trickier to position correctly. Some patients find them less comfortable for daily wear, particularly in warm weather.

Protecting Your Eyebrows During Treatment

While complete prevention of chemotherapy-induced hair loss isn’t currently possible, there are some evidence-based strategies that may help.

Scalp cooling (cold caps) have shown effectiveness in reducing scalp hair loss during certain chemotherapy regimens, but their effect on eyebrow preservation is less well-studied. Some patients report that scalp cooling helps preserve brow hair to some degree, but results are inconsistent.

Gentle handling of existing brow hair during treatment is important. Avoid tweezing, waxing, threading, or any other brow grooming that removes hair during treatment. Use gentle, fragrance-free cleansers around the eye area, and avoid rubbing the brow area aggressively when washing your face or applying skincare.

Nutritional support — ensuring adequate protein, biotin, zinc, and iron — supports overall hair health, though it cannot prevent chemotherapy-induced loss. Discuss supplementation with your oncology team, as some supplements may interact with treatment.

When Will Your Eyebrows Grow Back?

For the majority of patients, eyebrow regrowth does occur after chemotherapy ends. The timeline varies, but most patients see initial fine regrowth within 3 to 6 months of completing treatment. The regrowing brows may initially differ from your pre-treatment brows — they might be lighter, darker, finer, coarser, straighter, or curlier. These changes are usually temporary, and brows tend to return to their normal appearance within 12 to 18 months.

In rare cases — particularly with very high-dose chemotherapy regimens, stem cell transplants, or high-dose radiation to the brow area — regrowth may be incomplete or permanent loss may occur. If you experience persistent brow loss more than 18 months after treatment completion, a dermatologist can evaluate the follicles and discuss options.

You’re Not Alone in This

Losing your eyebrows during cancer treatment is a medical side effect — but it’s also a deeply personal experience. It changes how you see yourself in the mirror and how you feel walking into a room. It’s okay to care about that. Taking steps to manage your appearance during treatment isn’t vanity — it’s self-care, and it’s an important part of maintaining your sense of identity and normalcy during an abnormal time.

If you’re preparing for treatment or currently going through it, explore the options that feel right for you. Our full range of temporary eyebrow tattoos at Brow Again is designed to make one part of this journey a little easier — so you can focus on what matters most.

This article is for informational purposes only and does not constitute medical advice. Consult with your oncology team regarding any concerns about treatment side effects.